Skip to content
Review

Congenital myasthenic syndromes in Türkiye: genetic and clinical spectrum revisited in a nationwide pediatric cohort.

Aug 2026 · Neuromuscular Disorders · Vol 67, pp. 107399 · 0 citations · 34 references
Medicine

TL;DR

The results highlight the major contribution of a limited number of genes and underscore the importance of early molecular diagnosis in a population with high consanguinity and underscore the importance of early molecular diagnosis in a population with high consanguinity.

Abstract

Congenital myasthenic syndromes (CMS) are inherited disorders caused by defects in proteins essential for neuromuscular transmission. In this nationwide, multicenter retrospective study, we analyzed 133 genetically confirmed CMS cases from 118 unrelated families between 2017 and 2024 across 28 centers in Türkiye. Clinical, electrophysiological, and genetic data were collected from medical records. In addition, we performed a PubMed-based review of previously reported genetically confirmed Turkish CMS cases to place our findings in a broader national context. The median age at symptom onset, and the median diagnostic delay were 6 months and 24 months, respectively. Ocular involvement was the most common clinical feature, followed by respiratory and bulbar involvement. High consanguinity (82%) contributed to a predominance of homozygous variants. Variants were identified in 16 CMS-associated genes, with COLQ (34.6%), CHRNE (24.1%), and CHAT (12.8%) being the most frequent. Postsynaptic CMS was the most common anatomical subgroup. Eighteen novel variants across 11 genes expanded the mutational spectrum of CMS. Review of 23 previously published studies from Türkiye identified 139 additional genetically confirmed cases, showing a broadly similar genetic distribution, with CHRNE and COLQ predominating, followed by CHAT, whereas other CMS-associated genes were reported only sporadically. >These findings define the clinical and genetic landscape of CMS in Türkiye and, together with previously published Turkish cases, provide a broad national overview based on 272 genetically confirmed cases. The results highlight the major contribution of a limited number of genes and underscore the importance of early molecular diagnosis in a population with high consanguinity.

View source

Similar papers

Open access Sep 2026

Late-diagnosed congenital myasthenic syndrome due to a CHRNE mutation: a case report

Congenital myasthenic syndromes (CMS) comprise a heterogeneous group of inherited disorders caused by genetic defects affecting neuromuscular junction transmission. Clinical manifestations range from isolated ocular symptoms to severe neonatal respiratory insufficiency. Despite symptom onset early in life, CMS is frequ...

Pelin Yenilmez Yeşildaş, Nevra Öksüz · 0 citations
Open access Aug 2026

First Korean Case of DOK7 Congenital Myasthenic Syndrome Responsive to Ephedrine Therapy

The first Korean case of tyrosine kinase 7 CMS with a favorable therapeutic response to ephedrine is reported, emphasizing the need to consider CMS in the differential diagnosis of congenital myopathy.

Sangwon Joe, M. Choi, Yunjung Choi et al. · 0 citations
Open access Sep 2026

Clinical, genetic, and instrumental features of congenital myasthenic syndrome type 11

The phenotypic spectrum of CMS type 11 is characterized by a wide phenotypic spectrum – from a mild limb-girdle phenotype with extraocular involvement and childhood onset to severe forms with neonatal manifestation and respiratory failure, and early orthopedic complications.

E. Melnik, S. N. Bardakov, S. Nikitin et al. · 0 citations
Sep 2026

Allgrove syndrome in Colombia: clinical characterization and evidence of a possible founder effect

A highly prevalent AAAS variant suggestive of a possible founder effect was identified in the Paisa population and expanded the phenotypic spectrum and underscore the importance of early genetic testing and systematic multidisciplinary surveillance.

Johana Andrea Botero Hernandez, Eder Donadoni Varela Macias, María Victoria Lopera Cañaveral et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.